Triple-hit Lymphoma

• CLINICAL_TRIALS research · 2025-05-01
  Clinical Trial Update: A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies [Phase 1, Phase 2]

  IDP-121 is being studied in a Phase 1/2 trial for relapsed/refractory hematologic malignancies and is currently recruiting.

• CLINICAL_TRIALS trial_result · 2023-08-03
  Clinical Trial Update: XPO-1 in Combination With RCHOP for DH/TH Lymphoma [Phase 2]

  A Phase 2 clinical trial evaluating XPO-1 in combination with RCHOP for double hit and triple hit lymphoma is ongoing, with status currently…